Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 16/20 | 0.58 |
| ▸ | IKZF3 | Q9UKT9 | 15/20 | 0.58 |
| ▸ | TNF | P01375 | 4/20 | 0.52 |
| ▸ | IL1B | P01584 | 4/20 | 0.52 |
| ▸ | IKZF1 | Q13422 | 2/20 | 0.52 |
| ▸ | DDB1 | Q16531 | 2/20 | 0.52 |
| ▸ | BRD4 | O60885 | 1/20 | 0.52 |
| ▸ | IKZF2 | Q9UKS7 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31076731 | 0.88 | CRBN (0.60) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL25272437 | 0.88 | CRBN (0.60) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL25647388 | 0.84 | CRBN (0.54) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL30458918 | 0.83 | CRBN (0.50) | CRBNIKZF3 | |
| SCHEMBL31077283 | 0.83 | CRBN (0.72) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL25225443 | 0.83 | CRBN (0.72) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL31338076 | 0.82 | CRBN (0.60) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL25647384 | 0.82 | IKZF2 (0.55) | CRBNIKZF3IKZF1DDB1IKZF2 | |
| SCHEMBL31076539 | 0.82 | IKZF2 (0.55) | CRBNIKZF3IKZF1DDB1IKZF2 | |
| SCHEMBL31076618 | 0.81 | CRBN (0.71) | CRBNIKZF3TNFIL1BIKZF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4446324-A1 | LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2024-10-16 | — | — | EP | claimed |
| CN-116239566-A | E3 ubiquitin ligase ligand compound, protein degradation agent developed based on ligand compound and application thereof | 标新生物医药科技(上海)有限公司 | 2023-06-09 | — | — | CN | claimed |
| WO-2023104155-A1 | LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF | 标新生物医药科技(上海)有限公司 | 2023-06-15 | — | — | WO | disclosed |